Related references
Note: Only part of the references are listed.NUDT15 genetic variants are related to thiopurine-induced neutropenia in Thai children with acute lymphoblastic leukemia
Apichaya Puangpetch et al.
PHARMACOGENOMICS (2020)
Long-Term Outcomes of Modified St Jude Children's Research Hospital Total Therapy XIIIB and XV Protocols for Thai Children With Acute Lymphoblastic Leukemia
Pacharapan Surapolchai et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Hepatotoxicity During Maintenance Therapy and Prognosis in Children With Acute Lymphoblastic Leukemia
Maria S. Ebbesen et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial
Stine Nygaard Nielsen et al.
LANCET ONCOLOGY (2017)
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
T. Terwilliger et al.
BLOOD CANCER JOURNAL (2017)
Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia
Rochelle R. Maxwell et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2017)
The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment
Shoshana Rudin et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2017)
Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy
Lin Mei et al.
BLOOD REVIEWS (2015)
Acute Lymphoblastic Leukemia in Children
Stephen P. Hunger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia
Y. Tanaka et al.
PHARMACOGENOMICS JOURNAL (2015)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update
M. V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Acute lymphoblastic leukaemia
Hiroto Inaba et al.
LANCET (2013)
Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine
W. R. Wan Rosalina et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2012)
Comparative outcomes of Thai children with acute lymphoblastic leukemia treated with two consecutive protocols: 11-year experience
Pacharapan Surapolchai et al.
LEUKEMIA & LYMPHOMA (2012)
Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy
Tiphaine Adam de Beaumais et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Thiopurine S-Methyltransferase (TPMT) Polymorphisms in Children With Acute Lymphoblastic Leukemia, and the Need for Reduction or Cessation of 6-Mercaptopurine Doses During Maintenance Therapy: The Polish Multicenter Analysis
Jaroslaw Peregud-Pogorzelski et al.
PEDIATRIC BLOOD & CANCER (2011)
The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease
Hiromistu Ban et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia
Gauri Kapoor et al.
LEUKEMIA RESEARCH (2010)
Impact of the Heterozygous TPMT*1/*3C Genotype on Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients in Thailand
Suda Vannaprasaht et al.
CLINICAL THERAPEUTICS (2009)
Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine
Ahmed F. Hawwa et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Transporter-mediated protection against thiopurine-induced hematopoietic toxicity
Partha Krishnamurthy et al.
CANCER RESEARCH (2008)
Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore
Shirley Kow Yin Kham et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Determination of intra-ethnic differences in the polymorphisms of thiopurine S-methyltransferase in Chinese
JP Zhang et al.
CLINICA CHIMICA ACTA (2006)
Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)
AM Marinaki et al.
PHARMACOGENETICS (2004)
Thiopurine S-methyltransferase genetic polymorphism in the Thai population
S Srimartpirom et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations
JG Chang et al.
PHARMACOGENETICS (2002)